Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 27:
Steven Madden, Ltd. SHOO: This company that designs and markets branded footwear, accessories, and apparel via wholesale, direct-to-consumer, and licensing has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5% over the last 60 days.

Steven Madden, Ltd. price-consensus-chart | Steven Madden, Ltd. Quote
Steven Madden’s shares gained 30.7% over the last three months compared with the S&P 500’s advance of 0.8%. The company possesses a Momentum Score of B.

Steven Madden, Ltd. price | Steven Madden, Ltd. Quote
Day One Biopharmaceuticals, Inc. DAWN: This clinical-stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its next year earnings increasing 20.8% over the last 60 days.

Day One Biopharmaceuticals, Inc. price-consensus-chart | Day One Biopharmaceuticals, Inc. Quote
Day One’s shares gained 64.1% over the last three months compared with the S&P 500’s advance of 0.8%. The company possesses a Momentum Score of B.

Day One Biopharmaceuticals, Inc. price | Day One Biopharmaceuticals, Inc. Quote
Microchip Technology Incorporated MCHP: This manufacturer of smart, connected, and secure embedded control solutions has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.6% over the last 60 days.

Microchip Technology Incorporated price-consensus-chart | Microchip Technology Incorporated Quote
Microchip Technology’s shares gained 17.5% over the last three months compared with the S&P 500’s advance of 0.8%. The company possesses a Momentum Score of B.

Microchip Technology Incorporated price | Microchip Technology Incorporated Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| Sep-23 | |
| Sep-23 | |
| Sep-22 | |
| Sep-22 | |
| Sep-22 | |
| Sep-21 | |
| Sep-17 | |
| Sep-16 | |
| Sep-15 | |
| Sep-15 | |
| Sep-14 | |
| Sep-11 | |
| Sep-10 | |
| Sep-08 | |
| Sep-04 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite